Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
10.71
-0.04 (-0.37%)
At close: Oct 30, 2026, 4:00 PM EDT
10.74
+0.03 (0.26%)
After-hours: Oct 30, 2026, 7:56 PM EDT
Xeris Biopharma Holdings Market Cap
Xeris Biopharma Holdings has a market cap or net worth of $1.95 billion as of October 30, 2026. It is the 6,612th most valuable company in the world and the 1,782nd biggest in the United States. Its market cap has increased by 25.70% in one year.
Market Cap
1.95B
Enterprise Value
2.12B
1-Year Change
25.70%
Global Rank
Country Rank
#1,782 United States
Category
ChartMarket Cap Chart
Since October 6, 2021, Xeris Biopharma Holdings's market cap has increased from $295.78M to $1.95B, an increase of 560.18%. That is a compound annual growth rate of 45.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 1.95B | 49.91% |
| Dec 31, 2025 | 1.30B | 157.72% |
| Dec 31, 2024 | 505.39M | 55.70% |
| Dec 29, 2023 | 324.59M | 79.47% |
| Dec 30, 2022 | 180.86M | -50.50% |
| Dec 31, 2021 | 365.40M | 23.54% |
| Oct 6, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HUTCHMED (China) | 2.43B |
| Supernus Pharmaceuticals | 2.43B |
| Prestige Consumer Healthcare | 2.31B |
| Perrigo Company | 2.21B |
| BioCryst Pharmaceuticals | 2.16B |
| Trulieve Cannabis | 2.01B |
| Alvotech | 1.75B |
| Phibro Animal Health | 1.58B |